SCHEMBL6324360

SCHEMBL6324360

C[C@H](CO)N(CCN1CCCCC1)S(=O)(=O)c1ccc(C2=CC=CCC2=S)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.42
PSEN1 P49768 3/20 0.36
PSEN2 P49810 3/20 0.36
APH1B Q8WW43 3/20 0.36
NCSTN Q92542 3/20 0.36
APH1A Q96BI3 3/20 0.36
PSENEN Q9NZ42 3/20 0.36
MMP3 P08254 1/20 0.36
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
ABL1 P00519 2/20 0.34
SRC P12931 2/20 0.34
MMP2 P08253 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MMP13 P45452 1/20 0.34
MMP9 P14780 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326033 0.91 MMP2 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6768136 0.91 SIGMAR1 (0.42) SIGMAR1PSEN1PSEN2APH1BNCSTN
Hydrochloric Acid SCHEMBL6324127 0.90 SIGMAR1 (0.41) SIGMAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL6767719 0.81 MMP2 (0.40) SIGMAR1PSEN1PSEN2APH1BNCSTN
Hydrochloric Acid SCHEMBL6325647 0.81 MMP2 (0.39) SIGMAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL6407532 0.78 ADAMTS4 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6769197 0.78 ADAMTS4 (0.36) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6324353 0.76 KCNH2 (0.45) SIGMAR1PSEN1PSEN2APH1BNCSTN
SCHEMBL6324033 0.73 HRH3 (0.50) ALDH1A1SMN1; SMN2MMP13MMP9HRH3
SCHEMBL6330648 0.72 HRH3 (0.49) ALDH1A1SMN1; SMN2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014840-A1 Thiol sulfonamide metalloprotease inhibitors PHARMACIA CORPORATION 2005-01-20 US disclosed
US-6747027-B1 SELECTIVELY INHIBITS IN VITRO ACTIVITY OF HUMAN MATRIX METALLOPROTEASE-13 OVER IN VITRO ACTIVITY OF HUMAN MATRIX METALLOPROTEASE-1 PHARMACIA CORPORATION 2004-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014840-A1 Thiol sulfonamide metalloprotease inhibitors MMP12, MMP13, MMP3 SIGMAR1 4322/4885PSEN1 893/4885PSEN2 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.